Page last updated: 2024-08-23

substance p and Peripheral Nervous System Diseases

substance p has been researched along with Peripheral Nervous System Diseases in 54 studies

Research

Studies (54)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (7.41)	18.7374
1990's	15 (27.78)	18.2507
2000's	26 (48.15)	29.6817
2010's	8 (14.81)	24.3611
2020's	1 (1.85)	2.80

Authors

Authors	Studies
Feng, S; Mao, M; Wang, J; Wang, X; Zhang, S; Zhou, F	1
Hsieh, YL; Hu, ME; Ko, MH; Lan, CT; Tseng, TJ	1
Doppler, K; Ebentheuer, J; Ebert, S; Sommer, C; Trenkwalder, C; Uçeyler, N; Volkmann, J	1
Boi, M; Carozzi, VA; Cavaletti, G; Chiorazzi, A; Del Fiacco, M; Dorsey, SG; Marmiroli, P; Melis, T; Meregalli, C; Picci, C; Poddighe, L; Quartu, M; Renn, CL; Serra, MP	1
Abe, K; Chiba, T; Kambe, T; Kawakami, K; Koizumi, N; Oka, Y; Taguchi, K; Utsunomiya, I	1
Taguchi, K	1
Adler, JE; Skoff, AM; Zhao, C	1
Chikuma, T; Kato, T; Muramatsu, M; Takeda, K	1
Corder, G; Intondi, AB; Siegel, A; Taylor, BK; Zadina, JE; Zhang, X	1
Jasmin, L; Ohara, PT	1
Egashira, N; Kawashiri, T; Mihara, Y; Mishima, K; Oishi, R; Tatsushima, Y; Yano, T	1
Aman, K; Carlstedt, T; Dostrovsky, J; Hökfelt, T; Josephson, A; Landry, M; Lozano, AM; Spenger, C; Wiesenfeld-Hallin, Z	1
Boudah, A; Jasmin, L; Ohara, PT	1
Barbara, G; Busacchi, P; Corinaldesi, R; De Giorgio, R; Guerrini, S; Oliverio, C; Paradisi, R; Perri, T; Santini, D; Stanghellini, V	1
Ahmad, T; Bileviciute-Ljungar, I; Finn, A; Kreicbergs, A; Li, J; Ostenson, CG; Ugarph-Morawski, A	1
Batbayar, B; Fehér, E; Kövesi, G; Nagy, G; Zelles, T	1
Ordeberg, G	1
Blake, DR; Haigh, R; Mapp, PI; McCabe, CS; Shenker, NG	1
Cooper, RR; Jones, KB; Mollano, AV; Morcuende, JA; Saltzman, CL	1
Ohtori, S; Shimoyama, M; Shimoyama, N; Tanaka, K; Tatsuoka, H	1
Connor, B; Jamieson, SM; Liu, J; McKeage, MJ	1
Hong, JS; Schwasinger, ET; Tseng, LF; Wu, HE	1
Kakinoki, B; Ohgami, T; Saito, K; Sejima, M; Sekimoto, S; Yamagami, K; Yuki, S	1
Grorud, KW; Jensen, KT; Provenzano, PP; Vanderby, R	1
Authier, N; Balayssac, D; Coudoré, F; Coudoré-Civiale, MA; Eschalier, A; Ling, B	1
Chiang, H; Hsieh, ST; Hsieh, YL; Tseng, TJ	1
Hama, A; Herzberg, U; Sagen, J	1
Ding, M; Hald, A; Hansen, RR; Heegaard, AM; Nedergaard, S	1
Chase, TN; Engel, WK; Leeman, SE; Mrox, EA; Nutt, JG; Williams, AC	1
Curtis, J; de Blaquière, GE; Pereira, JH; Polak, JM; Santamaria, L; Terenghi, G; Turk, JL	1
Chatani, K; Gebhart, GF; Kawakami, M; Meller, ST; Spratt, KF; Traub, RJ; Weinstein, JN	1
Carrington, AL; Chen, S; Polak, JM; Terenghi, G; Tomlinson, DR	1
Abraham, RR; Berg, TJ; Levy, DM; Reid, G	1
Basile, S; Helme, RD; Khalil, Z	1
Carlton, SM; Dougherty, PM; Garrison, CJ	1
Colburn, RW; Coombs, DW; DeLeo, JA; Fromm, C; Twitchell, BB	1
Murray, M; Nothias, F; Tessler, A	1
Beitz, AJ; Brown, DR; Herzberg, U; Mullett, MA	1
Basbaum, AI; Malmberg, AB	1
Itoh, M; Iwaki, T; Kato, H; Matsuishi, T; Nagamitsu, S; Sakai, T; Shida, N; Shoji, H; Takashima, S; Yamashita, Y	1
Aloe, L; Lundeberg, T; Manni, L; Tirassa, P	1
Back, SK; Hong, SK; Kim, DY; Kim, HJ; Kim, JS; Na, HS; Sung, B	1
Aloe, L; De Santis, S; Fiore, M; Manni, L; Properzi, F	1
Bisby, MA; Ma, W	1
Ahn, SK; Lee, JE; Lee, WT; Park, KA; Park, SH; Sohn, MK	1
Cheema, SS; Kilpatrick, TJ; Lopes, EC; Phan, S; Reardon, K	1
Kastin, AJ; Martin-Schild, S; Smith, RR; Zadina, JE	1
Bertelli, A; Di Giulio, AM; Donadoni, L; Germani, E; Gorio, A; Mantegazza, P; Ramacci, MT; Tenconi, B	1
Harkness, DH; Larson, AA; Skilling, SR	1
Diemel, LT; Leach, RM; Smith, WJ; Tomlinson, DR	1
Cameron, AA; Carlton, SM; Cliffer, KD; Dougherty, PM; Willis, WD	1
Di Giulio, AM; Dona, M; Gorio, A; Mantegazza, P	1
Borella, F; Di Giulio, AM; Gorio, A; Hong, JS; Mantegazza, P; Panozzo, C; Zanoni, R	1
Cramer, H; Gagnieu, MC; Renaud, B; Rissler, K; Rösler, N	1

Reviews

4 review(s) available for substance p and Peripheral Nervous System Diseases

Article	Year
[Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2016, Volume: 136, Issue:2 Topics: Acute Disease; Animals; Antineoplastic Agents; Calcium Channels; Ganglia, Spinal; Gene Expression; Humans; Hyperalgesia; Molecular Targeted Therapy; Nerve Tissue Proteins; Organoplatinum Compounds; Oxaliplatin; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Peripheral Nervous System Diseases; Rats; Spinal Cord Dorsal Horn; Substance P; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPV Cation Channels; Up-Regulation	2016
Characterization of joint pain in human OA. Novartis Foundation symposium, 2004, Volume: 260 Topics: Arthralgia; Humans; Hyperalgesia; Nociceptors; Osteoarthritis; Pain Threshold; Peripheral Nervous System Diseases; Substance P	2004
Symmetry, T cells and neurogenic arthritis. Novartis Foundation symposium, 2004, Volume: 260 Topics: Arthritis; Arthropathy, Neurogenic; Calcitonin Gene-Related Peptide; Humans; Nerve Net; Peripheral Nervous System Diseases; Substance P; T-Lymphocytes	2004
Bone and brain: a review of neural, hormonal, and musculoskeletal connections. The Iowa orthopaedic journal, 2004, Volume: 24 Topics: Arthropathy, Neurogenic; Bone and Bones; Brain; Calcitonin Gene-Related Peptide; Catecholamines; Central Nervous System Diseases; Denervation; Glutamic Acid; Humans; Neuropeptides; Peripheral Nervous System Diseases; Substance P; Vasoactive Intestinal Peptide	2004

Other Studies

50 other study(ies) available for substance p and Peripheral Nervous System Diseases

Article	Year
Participation of transient receptor potential vanilloid 1 in the analgesic effect of duloxetine for paclitaxel induced peripheral neuropathic pain. Neuroscience letters, 2022, 03-16, Volume: 773 Topics: Analgesics; Animals; Antineoplastic Agents; Calcitonin Gene-Related Peptide; Duloxetine Hydrochloride; Ganglia, Spinal; Hyperalgesia; Neuralgia; Paclitaxel; Pain; Peripheral Nervous System Diseases; Rats; Spinal Cord Dorsal Horn; Substance P; TRPV Cation Channels; Tumor Necrosis Factor-alpha	2022
Peptidergic intraepidermal nerve fibers in the skin contribute to the neuropathic pain in paclitaxel-induced peripheral neuropathy. Neuropeptides, 2014, Volume: 48, Issue:3 Topics: Animals; Antineoplastic Agents, Phytogenic; Calcitonin Gene-Related Peptide; Epidermis; Male; Nerve Degeneration; Nerve Fibers; Neuralgia; Paclitaxel; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Substance P	2014
Cutaneous neuropathy in Parkinson's disease: a window into brain pathology. Acta neuropathologica, 2014, Volume: 128, Issue:1 Topics: Adult; Aged; Aged, 80 and over; alpha-Synuclein; Autonomic Pathways; Back; Brain; Female; Fingers; Humans; Leg; Male; Middle Aged; Nerve Degeneration; Neural Conduction; Parkinson Disease; Peripheral Nervous System Diseases; Phosphorylation; Skin; Substance P; Vitamins	2014
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve. BioMed research international, 2014, Volume: 2014 Topics: Animals; Behavior, Animal; Boronic Acids; Bortezomib; Calcitonin Gene-Related Peptide; Disease Models, Animal; Female; Ganglia, Spinal; Gene Expression Regulation; Nerve Tissue Proteins; Nociception; Peripheral Nervous System Diseases; Pyrazines; Rats; Rats, Wistar; Sciatic Nerve; Spinal Cord; Substance P; TRPV Cation Channels	2014
Paclitaxel-induced peripheral neuropathy increases substance P release in rat spinal cord. European journal of pharmacology, 2016, Jan-05, Volume: 770 Topics: Animals; Dose-Response Relationship, Drug; Gene Expression Regulation; Hyperalgesia; Male; Paclitaxel; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Receptors, Calcitonin Gene-Related Peptide; Spinal Cord; Substance P	2016
Interleukin-1alpha regulates substance P expression and release in adult sensory neurons. Experimental neurology, 2009, Volume: 217, Issue:2 Topics: Age Factors; Animals; Capsaicin; Cells, Cultured; Female; Ganglia, Spinal; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1alpha; Interleukin-1beta; Nerve Growth Factor; Neuralgia; Nociceptors; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sensory Receptor Cells; Sensory System Agents; Substance P; Up-Regulation	2009
Effect of memantine on the levels of neuropeptides and microglial cells in the brain regions of rats with neuropathic pain. Journal of molecular neuroscience : MN, 2009, Volume: 39, Issue:3 Topics: Analgesics; Animals; Brain; CD11 Antigens; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hyperalgesia; Hypothalamus; Male; Memantine; Microglia; Neuralgia; Neuropeptides; Periaqueductal Gray; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Sciatic Neuropathy; Somatostatin; Substance P	2009
A novel method to quantify histochemical changes throughout the mediolateral axis of the substantia gelatinosa after spared nerve injury: characterization with TRPV1 and substance P. The journal of pain, 2010, Volume: 11, Issue:4 Topics: Animals; Disease Models, Animal; Histocytochemistry; Image Processing, Computer-Assisted; Male; Peripheral Nervous System Diseases; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Spinal Nerve Roots; Staining and Labeling; Substance P; Substantia Gelatinosa; Synaptic Transmission; Thiamine Monophosphate; TRPV Cation Channels	2010
Close encounters of the third kind: evidence for contact with TNF-alpha. Pain, 2010, Volume: 151, Issue:2 Topics: Animals; Microglia; Models, Biological; Peripheral Nervous System Diseases; Substance P; Tumor Necrosis Factor-alpha	2010
Involvement of substance P in peripheral neuropathy induced by paclitaxel but not oxaliplatin. The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:1 Topics: Animals; Cells, Cultured; Ganglia, Spinal; Male; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Substance P	2011
Galanin expression in adult human dorsal root ganglion neurons: initial observations. Neuroscience, 2003, Volume: 117, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Calcitonin Gene-Related Peptide; Cell Size; Female; Galanin; Ganglia, Spinal; Headache; Herpes Zoster; Humans; Male; Middle Aged; Neurons, Afferent; Nociceptors; Pain; Peripheral Nerve Injuries; Peripheral Nerves; Peripheral Nervous System Diseases; Postmortem Changes; RNA, Messenger; Substance P	2003
Long-term effects of decreased noradrenergic central nervous system innervation on pain behavior and opioid antinociception. The Journal of comparative neurology, 2003, May-19, Volume: 460, Issue:1 Topics: Analgesics, Opioid; Animals; Antibodies, Monoclonal; Behavior, Animal; Biphenyl Compounds; Central Nervous System; Denervation; Disease Models, Animal; Disease Progression; Female; Hyperalgesia; Immunohistochemistry; Immunotoxins; Injections, Intraventricular; Injections, Spinal; Lumbosacral Region; Male; Morphine; Norepinephrine; Pain; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Ribosome Inactivating Proteins, Type 1; Saporins; Spinal Cord; Substance P; Time	2003
Abnormalities of somatic peptide-containing nerves supplying the pelvic floor of women with genitourinary prolapse and stress urinary incontinence. Urology, 2004, Volume: 63, Issue:3 Topics: Aged; Biomarkers; Biopsy; Birth Weight; Connective Tissue; Denervation; Female; Humans; Middle Aged; Models, Neurological; Muscle, Skeletal; Nerve Tissue Proteins; Neurons; Neuropeptide Y; Neuropeptides; Obesity; Parity; Pelvic Floor; Peripheral Nervous System Diseases; Phosphopyruvate Hydratase; Postmenopause; Rectum; S100 Proteins; Substance P; Urethra; Urinary Incontinence, Stress; Uterine Prolapse; Vasoactive Intestinal Peptide	2004
Bone and joint neuropathy in rats with type-2 diabetes. Regulatory peptides, 2004, Jun-15, Volume: 119, Issue:1-2 Topics: Animals; Bone and Bones; Bone Marrow; Calcitonin Gene-Related Peptide; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Female; Ganglia, Spinal; Glucose Tolerance Test; Immunohistochemistry; Joints; Neuropeptide Y; Neuropeptides; Peripheral Nervous System Diseases; Radioimmunoassay; Rats; Rats, Wistar; Substance P	2004
Morphological basis of sensory neuropathy and neuroimmunomodulation in minor salivary glands of patients with Sjögren's syndrome. Archives of oral biology, 2004, Volume: 49, Issue:7 Topics: Adult; Aged; Female; Galanin; Humans; Lymphocytes; Male; Mast Cells; Microscopy, Electron; Middle Aged; Nerve Fibers; Neuroimmunomodulation; Neuropeptide Y; Neuroprotective Agents; Peripheral Nervous System Diseases; Plasma Cells; Salivary Glands, Minor; Sjogren's Syndrome; Substance P; Tyrosine 3-Monooxygenase; Vasoactive Intestinal Peptide	2004
Change of dorsal horn neurochemistry in a mouse model of neuropathic cancer pain. Pain, 2005, Volume: 114, Issue:1-2 Topics: Animals; Calcitonin Gene-Related Peptide; Disease Models, Animal; Male; Mice; Mice, Inbred BALB C; Neoplasms; Pain; Peripheral Nervous System Diseases; Posterior Horn Cells; Substance P	2005
Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss. Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:4 Topics: Animals; Antineoplastic Agents; Female; Ganglia, Spinal; Neural Conduction; Organoplatinum Compounds; Oxaliplatin; Parvalbumins; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Substance P	2005
Pretreatment with antiserum against dynorphin, substance P, or cholecystokinin enhances the morphine-produced anti-allodynia in the sciatic nerve ligated mice. Neuroscience letters, 2005, Sep-23, Volume: 386, Issue:1 Topics: Analgesics, Opioid; Animals; Antibodies; Cholecystokinin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Dynorphins; Immune Sera; Injections, Spinal; Ligation; Male; Mice; Morphine; Neuralgia; Peripheral Nervous System Diseases; Sciatic Nerve; Sciatic Neuropathy; Substance P	2005
Orally active neurotrophin-enhancing agent protects against dysfunctions of the peripheral nerves in hyperglycemic animals. Diabetes, 2006, Volume: 55, Issue:3 Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Male; Nerve Growth Factor; Neural Conduction; Neuroprotective Agents; PC12 Cells; Peripheral Nervous System Diseases; Phosphorylation; Rats; Rats, Wistar; Receptor, trkA; Sialic Acids; Skin; Streptozocin; Substance P; Ubiquitin Thiolesterase	2006
Adjuvant neuropeptides can improve neuropathic ligament healing in a rat model. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2007, Volume: 25, Issue:6 Topics: Animals; Calcitonin Gene-Related Peptide; Disease Models, Animal; Female; Femoral Nerve; Ligaments; Neuropeptide Y; Neuropeptides; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Rupture; Substance P; Sympathectomy; Vasoactive Intestinal Peptide; Wound Healing	2007
Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat. Toxicology, 2007, May-20, Volume: 234, Issue:3 Topics: Analgesics, Non-Narcotic; Animals; Antineoplastic Agents; Behavior, Animal; Calcitonin Gene-Related Peptide; Carbamazepine; Hyperalgesia; Immunohistochemistry; Magnesium; Male; Neurons, Afferent; Organoplatinum Compounds; Oxaliplatin; Pain; Pain Measurement; Peripheral Nervous System Diseases; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Substance P	2007
Enhancement of cutaneous nerve regeneration by 4-methylcatechol in resiniferatoxin-induced neuropathy. Journal of neuropathology and experimental neurology, 2008, Volume: 67, Issue:2 Topics: Animals; Calcitonin Gene-Related Peptide; Capsaicin; Catechols; Disease Models, Animal; Diterpenes; Drug Interactions; Ganglia, Spinal; Hyperalgesia; Male; Mice; Mice, Inbred ICR; Nerve Fibers, Unmyelinated; Nerve Regeneration; Neural Conduction; Neuroprotective Agents; Peripheral Nervous System Diseases; Reaction Time; Skin; Substance P; Ubiquitin Thiolesterase	2008
Spinal subarachnoid adrenal medullary transplants reduce hind paw swelling and peripheral nerve transport following formalin injection in rats. Brain research, 2008, Mar-10, Volume: 1198 Topics: Adrenal Medulla; Afferent Pathways; Animals; Axonal Transport; Chromaffin Cells; Disease Models, Animal; GAP-43 Protein; Immunohistochemistry; Inflammation; Ligation; Male; Neurons, Afferent; Pain Measurement; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Substance P	2008
Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain. European journal of pain (London, England), 2009, Volume: 13, Issue:2 Topics: Animals; Behavior, Animal; Bone Neoplasms; Cell Line; Glial Fibrillary Acidic Protein; Gliosis; Immunohistochemistry; Mice; Mice, Inbred C3H; Neoplasms; Neuroglia; Pain; Pain Measurement; Peripheral Nervous System Diseases; Peripheral Nervous System Neoplasms; Physical Stimulation; Spinal Cord; Substance P; Tomography, X-Ray Computed	2009
Substance P in human cerebrospinal fluid: reductions in peripheral neuropathy and autonomic dysfunction. Neurology, 1980, Volume: 30, Issue:12 Topics: Adolescent; Adult; Aged; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Child; Corpus Striatum; Humans; Middle Aged; Neural Pathways; Neuromuscular Diseases; Peripheral Nervous System Diseases; Substance P; Substantia Nigra	1980
Denatured muscle grafts for nerve repair in an experimental model of nerve damage in leprosy. 2. Recovery of peripheral peptide-containing nerves assessed by quantitative immunohistochemical study. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1994, Volume: 62, Issue:1 Topics: Animals; Calcitonin Gene-Related Peptide; Granuloma; Guinea Pigs; Immunohistochemistry; Leprosy; Muscles; Neuropeptides; Peripheral Nervous System Diseases; Substance P; Thiolester Hydrolases; Ubiquitin Thiolesterase	1994
Experimental lumbar radiculopathy. Immunohistochemical and quantitative demonstrations of pain induced by lumbar nerve root irritation of the rat. Spine, 1994, Aug-15, Volume: 19, Issue:16 Topics: Animals; Calcitonin Gene-Related Peptide; Ganglia, Spinal; Genes, fos; Hot Temperature; Male; Nerve Compression Syndromes; Pain; Pain Threshold; Paralysis; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Nerve Roots; Substance P; Sutures; Vasoactive Intestinal Peptide	1994
Changes in sensory neuropeptides in dorsal root ganglion and spinal cord of spontaneously diabetic BB rats. A quantitative immunohistochemical study. Acta diabetologica, 1994, Volume: 31, Issue:4 Topics: Animals; Calcitonin Gene-Related Peptide; Diabetic Neuropathies; Ganglia, Spinal; Neurons, Afferent; Neuropeptides; Peripheral Nervous System Diseases; Rats; Rats, Inbred BB; Spinal Cord; Substance P	1994
The effects of vasoactive intestinal polypeptide and substance P on methacholine-induced sweating and vascular flare in diabetic neuropathy. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 1995, Volume: 5, Issue:3 Topics: Adult; Blood Vessels; Diabetic Neuropathies; Humans; Male; Methacholine Chloride; Middle Aged; Peripheral Nervous System Diseases; Substance P; Sweating; Vasoactive Intestinal Peptide	1995
Skin vascular reactivity to the neuropeptide substance P in rats with peripheral mononeuropathy. Pain, 1993, Volume: 52, Issue:2 Topics: Animals; Blister; Male; Nitroprusside; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sciatic Nerve; Skin; Substance P	1993
Quantitative analysis of substance P and calcitonin gene-related peptide immunohistochemical staining in the dorsal horn of neuropathic MK-801-treated rats. Brain research, 1993, Apr-02, Volume: 607, Issue:1-2 Topics: Animals; Calcitonin Gene-Related Peptide; Dizocilpine Maleate; Immunohistochemistry; Male; Pain; Perfusion; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P	1993
The ganglioside GM1 decreases autotomy but not substance P depletion in a peripheral mononeuropathy rat model. Anesthesia and analgesia, 1993, Volume: 77, Issue:3 Topics: Animals; Behavior, Animal; Disease Models, Animal; G(M1) Ganglioside; Male; Pain; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Self Mutilation; Spinal Cord; Substance P	1993
Restoration of substance P and calcitonin gene-related peptide in dorsal root ganglia and dorsal horn after neonatal sciatic nerve lesion. The Journal of comparative neurology, 1993, Aug-15, Volume: 334, Issue:3 Topics: Animals; Animals, Newborn; Calcitonin Gene-Related Peptide; Cell Survival; Female; Ganglia, Spinal; Immunohistochemistry; Male; Nerve Regeneration; Neurons; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Spinal Cord; Substance P	1993
Increased delayed type hypersensitivity in rats subjected to unilateral mononeuropathy is mediated by neurokinin-1 receptors. Journal of neuroimmunology, 1996, Volume: 65, Issue:2 Topics: Animals; Hypersensitivity, Delayed; Male; Microdialysis; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Sciatic Nerve; Substance P	1996
Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain, 1998, Volume: 76, Issue:1-2 Topics: Animals; Behavior, Animal; Hot Temperature; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Pain Measurement; Peripheral Nervous System Diseases; Physical Stimulation; Receptors, Neurokinin-1; Sciatic Nerve; Spinal Cord; Substance P; Sympathectomy, Chemical; Time Factors	1998
Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis. Short communication. Journal of neural transmission (Vienna, Austria : 1996), 1999, Volume: 106, Issue:9-10 Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Biomarkers; Female; Humans; Male; Middle Aged; Parkinson Disease; Peripheral Nervous System Diseases; Substance P	1999
Cholecystokinin-8 enhances nerve growth factor synthesis and promotes recovery of capsaicin-induced sensory deficit. British journal of pharmacology, 2000, Volume: 129, Issue:4 Topics: Animals; Behavior, Animal; Calcitonin Gene-Related Peptide; Capsaicin; Male; Mice; Nerve Growth Factor; Neurons, Afferent; Pain Threshold; Peripheral Nervous System Diseases; RNA, Messenger; Sincalide; Substance P; Up-Regulation	2000
Decrease in spinal CGRP and substance P is not related to neuropathic pain in a rat model. Neuroreport, 2001, Jan-22, Volume: 12, Issue:1 Topics: Animals; Calcitonin Gene-Related Peptide; Cold Temperature; Hot Temperature; Male; Pain; Peptide Fragments; Peripheral Nervous System Diseases; Physical Stimulation; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Spinal Nerves; Substance P	2001
Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis. Autonomic neuroscience : basic & clinical, 2000, Dec-28, Volume: 86, Issue:1-2 Topics: Animals; Antineoplastic Agents; Brain-Derived Neurotrophic Factor; Cisplatin; Male; Mice; Motor Activity; Nerve Growth Factor; Pain Measurement; Peripheral Nerves; Peripheral Nervous System Diseases; Reaction Time; Substance P; Sympathetic Fibers, Postganglionic	2000
Calcitonin gene-related peptide, substance P and protein gene product 9.5 immunoreactive axonal fibers in the rat footpad skin following partial sciatic nerve injuries. Journal of neurocytology, 2000, Volume: 29, Issue:4 Topics: Animals; Axons; Calcitonin Gene-Related Peptide; Disease Models, Animal; Foot; Immunohistochemistry; Male; Microscopy, Electron; Nerve Crush; Nerve Regeneration; Neuronal Plasticity; Nociceptors; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Sensory Receptor Cells; Skin; Substance P; Thiolester Hydrolases; Ubiquitin Thiolesterase	2000
Studies on the changes of c-fos protein in spinal cord and neurotransmitter in dorsal root ganglion of the rat with an experimental peripheral neuropathy. Yonsei medical journal, 2001, Volume: 42, Issue:1 Topics: Animals; Calcitonin Gene-Related Peptide; Ganglia, Spinal; Immunohistochemistry; Neurotransmitter Agents; Pain; Peripheral Nervous System Diseases; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P	2001
Leukaemia inhibitory factor abrogates Paclitaxel-induced axonal atrophy in the Wistar rat. Brain research, 2001, Aug-24, Volume: 911, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Axons; Calcitonin Gene-Related Peptide; Cell Count; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Ganglia, Spinal; Growth Inhibitors; Immunohistochemistry; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Nerve Degeneration; Neural Conduction; Neurons, Afferent; Paclitaxel; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Substance P	2001
Decreases in endomorphin-2-like immunoreactivity concomitant with chronic pain after nerve injury. Neuroscience, 2001, Volume: 105, Issue:3 Topics: Animals; Calcitonin Gene-Related Peptide; Chronic Disease; Down-Regulation; Functional Laterality; Hyperalgesia; Immunohistochemistry; Ligation; Male; Mice; Mice, Inbred ICR; Nerve Crush; Neuralgia; Oligopeptides; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Posterior Horn Cells; Reaction Time; Sciatic Nerve; Substance P	2001
Intraspinal degenerative atrophy caused by sciatic nerve lesions prevented by acetyl-L-carnitine. International journal of clinical pharmacology research, 1992, Volume: 12, Issue:5-6 Topics: Acetylcarnitine; Animals; Atrophy; Enkephalin, Methionine; Hydroxyindoleacetic Acid; Male; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Serotonin; Spinal Cord; Substance P	1992
Experimental peripheral neuropathy decreases the dose of substance P required to increase excitatory amino acid release in the CSF of the rat spinal cord. Neuroscience letters, 1992, May-11, Volume: 139, Issue:1 Topics: Amino Acids; Animals; Animals, Newborn; Behavior, Animal; Capsaicin; Dialysis; Male; Nociceptors; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Spinal Cord; Substance P	1992
Central hypoxaemia in rats provokes neurological defects similar to those seen in experimental diabetes mellitus: evidence for a partial role of endoneurial hypoxia in diabetic neuropathy. Neuroscience, 1991, Volume: 45, Issue:2 Topics: Animals; Diabetic Neuropathies; Glucose; Hypoxia; Inositol; Male; Nerve Tissue Proteins; Neural Conduction; Peripheral Nervous System Diseases; Rats; Rats, Inbred Strains; Sciatic Nerve; Skin; Sodium-Potassium-Exchanging ATPase; Substance P	1991
Changes in lectin, GAP-43 and neuropeptide staining in the rat superficial dorsal horn following experimental peripheral neuropathy. Neuroscience letters, 1991, Oct-14, Volume: 131, Issue:2 Topics: Animals; Calcitonin Gene-Related Peptide; GAP-43 Protein; Lectins; Male; Membrane Glycoproteins; Nerve Tissue Proteins; Neuropeptides; Peripheral Nervous System Diseases; Plant Lectins; Rats; Rats, Inbred Strains; Soybean Proteins; Spinal Cord; Staining and Labeling; Substance P	1991
Peripheral nerve lesions cause simultaneous alterations of substance P and enkephalin levels in the spinal cord. Brain research, 1985, Sep-09, Volume: 342, Issue:2 Topics: Animals; Enkephalin, Methionine; Male; Peripheral Nervous System Diseases; Rats; Rats, Inbred Strains; Spinal Cord; Substance P	1985
Structural and biochemical alterations in the dorsal horn of the spinal cord caused by peripheral nerve lesions. Peptides, 1985, Volume: 6 Suppl 3 Topics: Animals; Enkephalin, Methionine; Immunologic Techniques; Male; Peripheral Nerves; Peripheral Nervous System Diseases; Rats; Spinal Cord; Substance P; Time Factors	1985
Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease. Neuropeptides, 1988, Volume: 12, Issue:3 Topics: Adult; Cerebrospinal Fluid Proteins; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Immunoglobulin G; Male; Middle Aged; Peripheral Nervous System Diseases; Reference Values; Somatostatin; Spinal Cord Diseases; Substance P	1988